Article

Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(+)-H+ exchanger.

Department of Medicine, University of California, Los Angeles School of Medicine, USA.
Journal of Clinical Investigation (Impact Factor: 13.77). 06/1995; 95(5):2143-9. DOI: 10.1172/JCI117903
Source: PubMed

ABSTRACT Activation of cAMP-dependent protein kinase A inhibits the renal proximal tubule brush border membrane Na(+)-H+ exchanger by a process involving participation of a regulatory cofactor (NHE-RF) that is distinct from the transporter itself. Recent studies from this laboratory reported a partial amino acid sequence of this putative cofactor (Weinman, E. J., D. H. Steplock, and S. Shenolikar. 1993. J. Clin. Invest. 92:1781-1786). The present experiments detail the structure of the NHE-RF protein as determined from molecular cloning studies. A codon-biased oligonucleotide probe to a portion of the amino acid sequence of the putative cofactor was used to isolate a 1.9-kb cDNA from a rabbit renal library. The encoded protein is 358 amino acids in length and is rich in proline residues. Search of existing data bases indicates that NHE-RF is a unique protein. Using a reticulocyte lysate, the cDNA translated a product of approximately 44 kD, which was recognized by an affinity-purified polyclonal antibody to NHE-RF. Potential phosphorylation sites for protein kinase A are present. The mRNA for the protein is expressed in kidney, proximal small intestine, and liver. Reverse transcription/PCR studies in the kidney indicate the presence of mRNA for NHE-RF in several distinct nephron segments including the proximal tubule.

0 Bookmarks
 · 
45 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: NHERF1 is a multifunctional scaffolding protein that interacts with receptors and ion transporters in its PDZ domains, and with the Ezrin-Radixin-Moesin (ERM) family of proteins in its carboxy-terminus. The role of NHERF-1 in hepatocyte function remains largely unknown. Here we examine the distribution and physiological significance of NHERF1 and Mrp-2 in hepatocytes. A wild-type, radixin binding site mutant (F355R), and NHERF1 PDZ1- and PDZ2-domain adenoviral mutant constructs were tagged with yellow fluorescent protein (YFP) and expressed in polarized hepatocytes to study localization and function of NHERF1. Cellular distribution of NHERF1 and radixin was visualized by fluorescence microscopy. A CMFDA assay was used to characterize Mrp-2 function. Similar to Mrp-2, wild type NHERF-1 and the NHERF-1 PDZ2 deletion mutant were localized to the canalicular membrane. In contrast, the radixin binding site mutant (F355R) and the NHERF1 PDZ1 deletion mutant, which interacts poorly with Mrp-2, were rarely associated with the canalicular membrane. Knockdown of NHERF1 led to dramatically impaired CMFDA secretory response. The NHERF1 PDZ1 and F355R mutants were devoid of a secretory response using CMFDA, while wild type NHERF1 infected cells exhibited increased GSFM secretion. The data indicate that NHERF1 interacts with Mrp-2 via the PDZ1 domain of NHERF1. Further, the findings suggest that NHERF1 is essential for maintaining the localization and function of Mrp-2.
    AJP Cell Physiology 08/2014; · 3.67 Impact Factor
  • Source
    Cancer biomarkers: section A of Disease markers 01/2014; 14(2):177-184. · 1.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: NHERF1, NHERF2 and NHERF3 belong to the NHERF (Na+/H+ exchanger regulatory factor) family of PSD-95/Discs-large/ZO-1 (PDZ)-scaffolding proteins. Individually, each NHERF protein was shown involved in the regulation of multiple receptors or transporters including Na+/H+ exchanger 3 (NHE3). Though NHERF dimerizations have been reported, results have been inconsistent and the physiological function of NHERF dimerizations is still unknown. The current study semi-quantitatively compared the interaction strength among all possible homo-dimerizations and hetero-dimerizations of these three NHERF proteins by pull-down and co-immunoprecipitation assays. Both methods showed that NHERF2 and NHERF3 hetero-dimerize as the strongest interaction among all NHERF dimerizations. In vivo NHERF2/NHERF3 hetero-dimerization was confirmed by FRET and FRAP. NHERF2/NHERF3 hetero-dimerization is mediated by PDZ domains of NHERF2 and the carboxyl terminal PDZ domain recognition motif of NHERF3. The NHERF3-4A mutant is defective in hetero-dimerization with NHERF2 and does not support the inhibition of NHE3 by carbachol. This suggests a role for NHERF2/NHERF3 hetero-dimerization in the regulation of NHE3 activity. In addition, both PDZ domains of NHERF2 could be simultaneously occupied by NHERF3 and another ligand such as NHE3, α-actinin-4 and PKCα, promoting formation of NHE3 macro-complexes. This study suggests that NHERF2/NHERF3 hetero-dimerization mediates the formation of NHE3 macro-complexes, which are required for the inhibition of NHE3 activity by carbachol.
    Journal of Biological Chemistry 05/2014; · 4.60 Impact Factor

Full-text (2 Sources)

Download
11 Downloads
Available from
Jun 24, 2014